Assessment of Left Ventricular Myocardial Fibrosis and Edema in Atrial Fibrillation Using Cardiovascular Magnetic

Yanjing Wang1, Jing Zhou1, Yuhang Zhu2

  • 1Radiology Department, China-Japan Union Hospital of Jilin University.

Insights

Cardiovascular magnetic resonance (CMR) offers comprehensive assessment of atrial fibrillation (AF) patients. This study utilized multi-parametric quantitative analysis for improved clinical decisions and prognosis in AF management.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Population aging increases atrial fibrillation (AF) incidence, posing long-term prognosis challenges.
  • AF exacerbates atrial dysfunction and ventricular remodeling, elevating heart failure risk.
  • Cardiovascular magnetic resonance (CMR) is crucial for assessing cardiac function and pathology.

Purpose of the Study:

  • To comprehensively evaluate left atrium and left ventricle in AF patients using a one-stop CMR protocol.
  • To employ multi-parametric quantitative myocardial analysis for precise assessment.
  • To provide reliable data for clinical treatment, preoperative evaluation, and long-term follow-up.

Main Methods:

  • Utilized a one-stop Cardiovascular Magnetic Resonance (CMR) protocol.
  • Incorporated multi-parametric quantitative myocardial analysis techniques: T1 mapping, T2 mapping, and extracellular volume (ECV) fraction.
  • Assessed functional abnormalities and myocardial pathology in both atria and ventricles.

Main Results:

  • Demonstrated CMR's capability for accurate functional assessment of atria and ventricles.
  • Showcased quantitative techniques (T1, T2 mapping, ECV) for early and precise ventricular myocardial pathology quantification.
  • Provided comprehensive data on left atrium and left ventricle in AF patients.

Conclusions:

  • A one-stop CMR protocol with multi-parametric quantitative analysis enables thorough cardiac assessment in AF patients.
  • This approach provides reliable data crucial for informed clinical decisions, preoperative planning, and patient follow-up.
  • Highlights the utility of advanced CMR techniques in managing the long-term prognosis of atrial fibrillation.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...